These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38411517)

  • 1. Direct and Indirect Chimeric Antigen Receptor T-Cell Imaging with PET/MRI in a Tumor Xenograft Model.
    Kim SY; Soh H; Jung JH; Cho EH; Kim H; Ju JM; Sheen JH; Lee SJ; Oh SJ; Lee SJ; Chung J; Ryu JS
    Radiology; 2024 Feb; 310(2):e231406. PubMed ID: 38411517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of real-time in vivo 89Zr-DFO-labeled CAR T-cell trafficking using PET imaging.
    Lee SH; Soh H; Chung JH; Cho EH; Lee SJ; Ju JM; Sheen JH; Kim H; Oh SJ; Lee SJ; Chung J; Choi K; Kim SY; Ryu JS
    PLoS One; 2020; 15(1):e0223814. PubMed ID: 31910217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatio-temporal biodistribution of
    Sta Maria NS; Khawli LA; Pachipulusu V; Lin SW; Zheng L; Cohrs D; Liu X; Hu P; Epstein AL; Jacobs RE
    Sci Rep; 2021 Jul; 11(1):15077. PubMed ID: 34302002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of in vivo CAR T cells tracking using streptavidin-biotin-paired positron emission tomography.
    Pan D; Wang Y; Xu N; Xu Y; Wang X; Wang L; Yan J; Yu L; Miao L; Wang G; Yang M
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4419-4426. PubMed ID: 35902411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility study of
    Wang XY; Wang Y; Wu Q; Liu JJ; Liu Y; Pan DH; Qi W; Wang LZ; Yan JJ; Xu YP; Wang GJ; Miao LY; Yu L; Yang M
    Acta Pharmacol Sin; 2021 May; 42(5):824-831. PubMed ID: 32901086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors.
    Ugur O; Kothari PJ; Finn RD; Zanzonico P; Ruan S; Guenther I; Maecke HR; Larson SM
    Nucl Med Biol; 2002 Feb; 29(2):147-57. PubMed ID: 11823119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET.
    Simonetta F; Alam IS; Lohmeyer JK; Sahaf B; Good Z; Chen W; Xiao Z; Hirai T; Scheller L; Engels P; Vermesh O; Robinson E; Haywood T; Sathirachinda A; Baker J; Malipatlolla MB; Schultz LM; Spiegel JY; Lee JT; Miklos DB; Mackall CL; Gambhir SS; Negrin RS
    Clin Cancer Res; 2021 Feb; 27(4):1058-1068. PubMed ID: 33087332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specifically labeled
    Kristensen LK; Christensen C; Jensen MM; Agnew BJ; Schjöth-Frydendahl C; Kjaer A; Nielsen CH
    Theranostics; 2019; 9(15):4409-4420. PubMed ID: 31285769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational Development of a Zr-89-Labeled Inhibitor of Prostate-specific Membrane Antigen for PET Imaging in Prostate Cancer.
    Vázquez SM; Endepols H; Fischer T; Tawadros SG; Hohberg M; Zimmermanns B; Dietlein F; Neumaier B; Drzezga A; Dietlein M; Schomäcker K
    Mol Imaging Biol; 2022 Feb; 24(1):115-125. PubMed ID: 34370181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD19 chimeric antigen receptor T cell therapy in leukemia xenograft mouse: Anti-leukemic efficacy, kinetics, and 4-week single-dose toxicity.
    Kim JI; Park MY; Kwon E; Kang HJ; Kang BC
    Toxicol Appl Pharmacol; 2023 Sep; 475():116628. PubMed ID: 37506978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with
    Leland P; Kumar D; Nimmagadda S; Bauer SR; Puri RK; Joshi BH
    J Transl Med; 2023 Jun; 21(1):367. PubMed ID: 37286997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with
    Weist MR; Starr R; Aguilar B; Chea J; Miles JK; Poku E; Gerdts E; Yang X; Priceman SJ; Forman SJ; Colcher D; Brown CE; Shively JE
    J Nucl Med; 2018 Oct; 59(10):1531-1537. PubMed ID: 29728514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity comparison of humanized CD19 CAR-T cells with murine CD19 CAR-T on Nalm-6 cells and xenograft tumor model].
    Wang J; Mou N; Meng JX; Li X; Jiang YY; Yuan T; Deng Q
    Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):827-832. PubMed ID: 34407586
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions.
    Heidari P; Kunawudhi A; Martinez-Quintanilla J; Szretter A; Shah K; Mahmood U
    Theranostics; 2018; 8(12):3380-3391. PubMed ID: 29930736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ShRNA-mediated silencing of PD-1 augments the efficacy of chimeric antigen receptor T cells on subcutaneous prostate and leukemia xenograft.
    Zhou JE; Yu J; Wang Y; Wang H; Wang J; Wang Y; Yu L; Yan Z
    Biomed Pharmacother; 2021 May; 137():111339. PubMed ID: 33550044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging expression of the human somatostatin receptor subtype-2 reporter gene with 68Ga-DOTATOC.
    Zhang H; Moroz MA; Serganova I; Ku T; Huang R; Vider J; Maecke HR; Larson SM; Blasberg R; Smith-Jones PM
    J Nucl Med; 2011 Jan; 52(1):123-31. PubMed ID: 21149478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 68Ga-DOTATOC and FDG PET Imaging of Preclinical Neuroblastoma Models.
    Provost C; Prignon A; Cazes A; Combaret V; Delattre O; Janoueix-Lerosey I; Montravers F; Talbot JN
    Anticancer Res; 2016 Sep; 36(9):4459-66. PubMed ID: 27630282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing
    Cho H; Al-Saden N; Lam H; Möbus J; Reilly RM; Winnik MA
    Nucl Med Biol; 2020; 84-85():11-19. PubMed ID: 31931305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with
    Al-Saden N; Lam K; Chan C; Reilly RM
    Mol Pharm; 2018 Aug; 15(8):3383-3393. PubMed ID: 29957952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes.
    Krebs S; Ahad A; Carter LM; Eyquem J; Brand C; Bell M; Ponomarev V; Reiner T; Meares CF; Gottschalk S; Sadelain M; Larson SM; Weber WA
    J Nucl Med; 2018 Dec; 59(12):1894-1900. PubMed ID: 29903928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.